Finally, a documented substance dependence was associated with fewer instances of symptom improvement than expected in the TAU+ILF patient group, which was found to be significant asymptotically (p < 0.001) but did not meet the significance threshold under Fisher’s Exact Test (p = 0.061, Table 11). This evidence concerns the gene FOXK2 and substance dependence.